Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
1970-01-01 08:00
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish
1970-01-01 08:00
Medical device makers rise on relief after Wegovy obesity trial data
Shares of U.S. medical device makers climbed in early trading on Monday as a potential hit from the
1970-01-01 08:00
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker
1970-01-01 08:00
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
1970-01-01 08:00
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN Novo Nordisk wants to buy more companies with drugs in early-
1970-01-01 08:00
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
1970-01-01 08:00
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
1970-01-01 08:00
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
1970-01-01 08:00
Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
1970-01-01 08:00
U.S. FDA found lapses at Novo's main U.S. factory in May 2022 -report
By Maggie Fick LONDON (Reuters) -U.S. drug regulators issued a report detailing quality control lapses at Novo Nordisk's main factory
1970-01-01 08:00
The maker of Wegovy and Ozempic is now Europe's most valuable company
Novo Nordisk has dethroned Bernard Arnault's luxury goods giant LVMH as Europe's most valuable company.
1970-01-01 08:00